Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04160832 · ClinicalTrials.gov registry record
Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps
A clinical trial of Colorectal Neoplasm, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT04160832: Completed study of Colorectal Neoplasm, sponsored by University of Colorado, Denver.
NCT04160832 is a study of Colorectal Neoplasm that has completed, run by University of Colorado, Denver. The registered enrollment target is 200 participants, roughly in line with the 219-participant average among 4 other Colorectal Neoplasm trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04160832, a study of Colorectal Neoplasm, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The study is being conducted to determine the prevalence and risk factors for germline cancer susceptibility genetic mutations among patients with advanced colorectal polyps.
Conditions Studied
Interventions
- GENETIC Multi-Cancer Cancer Panel
Study Locations (1)
Colorado
- University of Colorado Denver - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2019-10-24 |
| Est. Completion | 2024-08-30 |
What the finished NCT04160832 record still lists
NCT04160832 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 219-participant average among 4 other Colorectal Neoplasm trials with a reported enrollment target.
The record links to 1 condition, with Colorectal Neoplasm appearing as the primary indexed condition, and to 1 intervention - of which Multi-Cancer Cancer Panel is the first listed.
NCT04160832 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT04160832 about?
NCT04160832 is a clinical study titled "Prevalence and Spectrum of Cancer Susceptibility Among Patients with Advanced Colorectal Polyps". The study is being conducted to determine the prevalence and risk factors for germline cancer susceptibility genetic mutations among patients with advanced colorectal polyps.
What is the current status of trial NCT04160832?
This trial is currently completed. The enrollment target is 200 participants. The study started on 2019-10-24. Estimated completion is 2024-08-30.
What conditions does trial NCT04160832 study?
This clinical trial studies the following conditions: Colorectal Neoplasm.
What interventions are being tested in trial NCT04160832?
The interventions under investigation include: Multi-Cancer Cancer Panel (GENETIC).
Who is sponsoring clinical trial NCT04160832?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04160832 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Colorectal Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Testing a Combination of Vaccines for Cancer Prevention in Lynch Syndrome
ACTIVE NOT RECRUITING · Phase 2
-
Decision Aid Website in Helping to Make Decisions About Fertility in Participants With Cancer
ACTIVE NOT RECRUITING · NA
-
Clinical Study of Real Time Colorectal Polyp Diagnosis During Colonoscopy - the VALID Colonoscopy Study
COMPLETED · NA
-
Evaluating the Safety and Effectiveness of the Flex Robotic System for the Surgical Removal of Colorectal Lesions
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI